Source: Hematology, Transfusion and Cell Therapy. Unidades: ICB, FCF, FM
Subjects: FARMACOLOGIA, NEOPLASIAS POR TIPO HISTOLÓGICO, LINFÓCITOS B, CÉLULAS CULTIVADAS DE TUMOR, ANTINEOPLÁSICOS, LEUCEMIA MIELOIDE AGUDA, CROMATINA, INIBIDORES DE ENZIMAS
ABNT
GARNIQUE, Anali Del Milagro Bernabe et al. Hybrid histone deacetylase-kinase inhibitor potentiates venetoclax-induced cell death in chronic lymphocytic leukemia. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2025.103757. Acesso em: 24 maio 2025. , 2025APA
Garnique, A. D. M. B., Carlos, J. A. E. G., Parducci, N. S., Tavares, M. T., Waitaman, K. de B., Lima, K., et al. (2025). Hybrid histone deacetylase-kinase inhibitor potentiates venetoclax-induced cell death in chronic lymphocytic leukemia. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/j.htct.2025.103757NLM
Garnique ADMB, Carlos JAEG, Parducci NS, Tavares MT, Waitaman K de B, Lima K, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. Hybrid histone deacetylase-kinase inhibitor potentiates venetoclax-induced cell death in chronic lymphocytic leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2025 ; 47( 2): 5 .[citado 2025 maio 24 ] Available from: https://doi.org/10.1016/j.htct.2025.103757Vancouver
Garnique ADMB, Carlos JAEG, Parducci NS, Tavares MT, Waitaman K de B, Lima K, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. Hybrid histone deacetylase-kinase inhibitor potentiates venetoclax-induced cell death in chronic lymphocytic leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2025 ; 47( 2): 5 .[citado 2025 maio 24 ] Available from: https://doi.org/10.1016/j.htct.2025.103757